Considering that HGSNAT is a lysosomal transmembrane protein that does not shuttle through the 6-mannose phosphate pathway, Sanfilippo C syndrome might not be the best candidate for this therapeutic strategy. Here, HGSNAT is linked to mucopolysaccharidosis type 3C.